Article Text

Download PDFPDF
Nested case-control study
Inhaled anticholinergic medications in older men with chronic obstructive pulmonary disorder are associated with increased odds of acute urinary retention

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Competing interests DDS has received grants from Pfizer and Boehringer Ingelheim, makers of inhaled anticholinergics, as well as from AstraZeneca and GlaxoSmithKline, makers of long-acting β-2 agonists.